Results 1 to 10 of about 37,426 (244)

Predictive Value of C-reactive Protein for Hospitalization and Mortality Among People With Advanced HIV Disease in Uganda Receiving the World Health Organization-recommended Package of Care. [PDF]

Clin Infect Dis
Schwartz EL, Nalintya EK, Skipper CP, Nerima P, Fieberg AM, Namakula OL, Dai B, Meya DB, Boulware DR, Rajasingham R.   +9 more
europepmc   +1 more source

Seroepidemiology and Reactivation Rates of Cytomegalovirus in HIV-Positive Patients in Istanbul: A Retrospective Analysis. [PDF]

Viruses
Sevimli Saydan D, Kir MH, Köksal MO, Sarsar K, Hulikyan A, Cagatay A, Demirci M, Soguksu P, Yurtseven E, Akkoyunlu SZ, Meşe S, Agacfidan A, Kirkoyun Uysal H.   +12 more
europepmc   +1 more source

Genotype distribution of <i>Pneumocystis jirovecii</i> in immunocompromised patients: a single-center molecular epidemiology study. [PDF]

Front Fungal Biol
Alencar CS, Magri MMC, Caiaffa Filho HH, Sabino EC.   +3 more
europepmc   +1 more source

Patients at Risk for AIDS-Related Opportunistic Infections

New England Journal of Medicine, 1985
We studied 81 men (79 homosexuals and 2 drug abusers) with persistent lymphadenopathy to determine whether those at risk for AIDS-related opportunistic infections could be identified prospectively. (Sixty-nine of 76 [91 per cent] had antibodies to human T-cell lymphotropic virus Type III [HTLV-III], and 76 of 79 [96 per cent] had abnormal T4/T8 cell ...
Henry W Murray, Murray Henry W, B Y Rubin   +2 more
exaly   +3 more sources

Systemic Antifungal Agents Against AIDS-Related Opportunistic Infections: Current Status and Emerging Drugs in Development

Current Medicinal Chemistry, 1999
No effective drug was available for the treatment of systemic fungal infections until the discovery of Amphotericin 8 in 1953. Since then flucytosine, azoles and later the triazoles, have now become available. The current interest in the development of new antifungal agents can partially be explained by the dramatic rise in the number of AIDS cases ...
Seth Ablordeppey
exaly   +3 more sources

When to Start ART in the Setting of Acute AIDS-Related Opportunistic Infections: The Time Is Now!

Current HIV/AIDS Reports, 2012
Despite the substantial benefits of combination antiretroviral therapy (ART), a significant proportion of HIV-infected individuals still present with advanced disease and active AIDS-related opportunistic infections (OIs). The weight of evidence from recent studies supports the early initiation of ART (ie, within 2 weeks of initiating treatment for the
Philip M Grant, Andrew R Zolopa, Grant Philip M   +2 more
exaly   +3 more sources

AIDS related opportunistic infections, going but not gone

Archives of Pharmacal Research, 2002
It is now more than two decades since the AIDS epidemic began with a cluster of Pneumocystis carinii pneumonia (PCP) in a community of homosexual men. Since then, many other infections have been characterized as opportunistic infections secondary to HIV infection. These include, but are not limited to, infections with Toxoplasma gondii, Cytomegalovirus
Rafik, Samuel, Robert L, Bettiker, Byungse, Suh   +2 more
openaire   +2 more sources

Experimental Results on Chloroquine and AIDS-Related Opportunistic Infections

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
Apart from its antiretroviral effects, chloroquine (CQ) has other properties that may be of interest in setting of HIV infection. First, it is an anti-inflammatory drug and, second, it may help to prevent several AIDS-related opportunistic infections.
Boelaert JR, Appelberg R, Gomes MS, BLASI, Elisabetta, Mazzolla R, Grosset J, Lounis N, Soteriadou K, Thiakaki M, Taramelli D, Tognazioli C.   +10 more
openaire   +3 more sources